CastleArk Alternatives’s Omnicell OMCL Stock Holding History

CastleArk Alternatives’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-69,535	Closed	-$10.3M	–	201
2021 Q3	$10.3M	Buy	+69,535	New	+$10.7M	0.39%	66

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CastleArk Alternatives's OMCL Position: Q4 2021 in Review

CastleArk Alternatives sold out of Omnicell (OMCL) in Q4 2021, closing a stake of 69,535 shares — an estimated $10.3M sold.

CastleArk Alternatives first reported a position in OMCL in Q3 2021 and held it in 1 quarter. The position peaked at $10.3M in Q3 2021. 422 funds tracked by Wall St. Rank hold OMCL as of Q4 2021.

CastleArk Alternatives reported no remaining Omnicell position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 69,535 Omnicell shares in Q4 2021, an estimated $10.3M.
CastleArk Alternatives first reported a position in Omnicell in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's Omnicell position peaked at $10.3M in Q3 2021.
422 funds tracked by Wall St. Rank held Omnicell as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.